Partner with the Only Industry-Dedicated In Vivo Engineering Meeting to Maximize your Influence
Following an explosion of excitement across the in vivo engineering field in 2022, it has ushered in a new era of cell and gene therapy, with collaborations and investments showing no signs of slowing down.
Whilst the in vivo approach holds powerful potential to transform the entire cell and gene space, the leading industry experts in the field have mentioned they require meaningful partnerships to achieve their early research objectives.
The In Vivo Engineering of Therapeutic Cells Summit provides the unique opportunity to position your trusted expertise to those at the forefront of in vivo engineered therapy development in biotech and pharma. Ensure you capitalize on market share early and show your support in the growth of these therapies.
From our research, it has become clear that the leading drug developers in the field need help from service providers and require meaningful partnerships to aid with raw material supply, research development, vector manufacturing (i.e., AAV, lentivirus, mRNA, LNP), and more.
Why Sponsor the In Vivo Engineering of Therapeutic Cells Summit?
Position Yourself as an Industry Thought Leader: Now is your chance to get in front of your target key decision makers in the market and demonstrate your expertise through podium presentations, moderating panel discussions or interactive roundtables.
Raise Brand Awareness: Increase your reach and exposure to new clients, customers, and businesses through unique branding opportunities pre and post conference.
Meet and Network with Industry Pioneers: With a room full of drug developers looking to see how they can effectively begin development of in vivo engineered cell and gene therapies, fill your pipeline with new leads for 2023 and beyond through one-to-one meetings and networking opportunities.
Benefit from Market Intelligence: Discover what solutions and services biopharma companies will be investing in to produce in vivo engineered cell and gene therapies on large scales in 2023 to enable you to match your solutions accordingly.